Article

Personalized Pharma Packaging

A keynote session at CPhI will discuss how the trend to personalized medicine affects pharmaceutical packaging.

At CPhI Worldwide, Christopher Waterhouse, managing director of iDi Pac, will present a keynote session “A Personal Approach to Pharma Packaging: Shifting from Large Volumes to Personalized Solutions.” The presentation will discuss how the trend to personalized medicine and smaller batch sizes affects packaging. 

The need to produce small batches results in a need for packaging solutions to facilitate the delivery of digital capability (i.e., artwork, print), but this increases cost of goods, especially in the small-volume areas (e.g., gene therapies, oncology), notes Waterhouse. 

In addition, the need for multi-lingual information delivery and aging populations is driving a need to deliver more complex information more accessibly. “Information can be delivered through a variety of media, most effectively either by digitally generated hard-copy ‘booklets’ (for the patient's unique treatment regime) or via smart barcode technology connecting via digital bridges to client servers and information resources,” says Waterhouse.

This session will be presented in the Innopack/P-MEC Theatre (4F121) on Tuesday, Oct. 9, 2018, at 11:10 am. 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content